Are you Dr. Sorscher?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 68 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
619 19th Street South
Birmingham, AL 35233Phone+1 205-934-6600- Is this information wrong?
Summary
- Dr. Eric Sorscher, MD is an oncologist in Birmingham, Alabama. He is currently licensed to practice medicine in Alabama. He is a Professor at University of Alabama School of Medicine.
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1990
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1989
- Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986
- Harvard Medical SchoolClass of 1984
Certifications & Licensure
- AL State Medical License 1990 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1998
Clinical Trials
- Trikafta in Cystic Fibrosis Patients Start of enrollment: 2019 Sep 04
Publications & Presentations
PubMed
- 6 citationsImproved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination.Jennifer L. Goeckeler-Fried, Rajiah Aldrin Denny, Disha Joshi, Clare Hill, Mads B. Larsen, Annette N. Chiang, Raymond A. Frizzell, Peter Wipf, Eric J. Sorscher, Jeffre...> ;Bioorganic & Medicinal Chemistry Letters. 2021 Sep 15
- 47 citationsA small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.Jyoti Sharma, Ming Du, Eric Wong, Venkateshwar Mutyam, Yao Li, Jianguo Chen, Jamie R Wangen, Kari Thrasher, Lianwu Fu, Ning Peng, Liping Tang, Kaimao Liu, Bini Mathew,...> ;Nature Communications. 2021 Jul 16
- 25 citationsAntisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutationYifat S. Oren, Michal Irony-Tur Sinai, A. Golec, Ofra Barchad-Avitzur, Venkateshwar Mutyam, Yao Li, Jeong S. Hong, Efrat Ozeri-Galai, A. Hatton, Chen Leibson, Liran Ca...> ;Journal of Cystic Fibrosis. 2021 Jul 2
- Join now to see all